Pharmacological targeting of SF3a1-MDM4 splicing vulnerability in ovarian cancer with rifaximin and antisense oligonucleotide. [PDF]
Shuai X +5 more
europepmc +1 more source
Exploring effectiveness of Metronidazole, Bismuth, and Rifaximin in treating small intestinal bacterial overgrowth and irritable bowel syndrome: A systematic review. [PDF]
Shah Q, Soldera J.
europepmc +1 more source
Reducing the Risk of Overt Hepatic Encephalopathy Recurrence: A Narrative Review. [PDF]
Pyrsopoulos NT +3 more
europepmc +1 more source
The Management of Irritable Bowel Syndrome: A Position Paper of the Neurogastroenterology and Motility Section of the Israeli Gastroenterology Association. [PDF]
Shibli F +15 more
europepmc +1 more source
Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses. [PDF]
Palenca I +4 more
europepmc +1 more source
The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research. [PDF]
Wang W, Wen Y.
europepmc +1 more source
Proximity-ligation metagenomics reveals differential plasmid and chromosomal antimicrobial resistance gene carriage in disrupted gut ecosystems. [PDF]
Sommer AJ, Auch B, Khoruts A, Bajaj JS.
europepmc +1 more source
Role of Bile Acid Receptors in Non-Infectious Diarrhea: A Narrative Review. [PDF]
Pan L +7 more
europepmc +1 more source
Relationship between small intestinal bacterial overgrowth and irritable bowel syndrome and the efficacy of rifaximin intervention: a systematic review and meta-analysis. [PDF]
Lu H.
europepmc +1 more source

